S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: Asian shares meander after S&P 500 sets another record
The Most Bought AI Stock by Congress Isn’t NVIDIA
5 Dividend Kings Stocks to Load Up on Now
Chinese leader Xi issues a positive message at a meeting with US business leaders as ties improve
Palantir Technologies: Bearish Sentiment, Bullish Chart Signals
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
NYSE:RAD

Rite Aid (RAD) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.39
$1.89
52-Week Range
N/A
Volume
5,426 shs
Average Volume
4.16 million shs
Market Capitalization
$34.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$1.00

Rite Aid MarketRank™ Stock Analysis

Analyst Rating
0.00 Rating Score
Upside/​Downside
∞ Upside
$1.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
-1.85
Upright™ Environmental Score
News Sentiment
-0.01mentions of Rite Aid in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($4.75) to ($3.35) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.15 out of 5 stars

Retail/Wholesale Sector

191st out of 195 stocks

Drug Stores & Proprietary Stores Industry

4th out of 4 stocks

RAD stock logo

About Rite Aid Stock (NYSE:RAD)

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line. It also operates retail pharmacies and clinics; and offers healthcare services, including administering immunizations for COVID-19, the flu, shingles, and others; assists its customers with high blood pressure, cholesterol, and diabetes; provides guidance on combating obesity and tobacco addiction; and educates customers on managing medications and potential side effects. The Pharmacy Services segment provides integrated suite of pharmacy benefit management (PBM) offerings, including technology solutions, mail delivery services, specialty pharmacy, network and rebate administration, claims adjudication, and pharmacy discount programs, as well as drug benefits under the federal government's Medicare Part D program and insurance offerings for individuals and groups. This segment serves health plans, commercial employers, labor groups, and state and local governments. In addition, it offers its products through online retail site. Rite Aid Corporation was founded in 1962 and is headquartered in Philadelphia, Pennsylvania.

RAD Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
See More Headlines
Receive RAD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rite Aid and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
4/20/2023
Today
3/28/2024
Fiscal Year End
2/28/2025

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Drug Retail
CUSIP
76775410
Employees
47,000
Year Founded
1968

Price Target and Rating

Average Stock Price Target
$1.00
High Stock Price Target
$1.00
Low Stock Price Target
$1.00
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-749,940,000.00
Pretax Margin
-4.02%

Debt

Sales & Book Value

Annual Sales
$24.09 billion
Book Value
($11.35) per share

Miscellaneous

Free Float
55,800,000
Market Cap
$34.71 million
Optionable
Optionable
Beta
1.25

Social Links

10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Ms. Elizabeth H. Burr (Age 61)
    Interim CEO & Director
    Comp: $698.46k
  • Mr. Matthew C. Schroeder (Age 53)
    CFO & Exec. VP
    Comp: $822.52k
  • Mr. Steven K. Bixler (Age 44)
    Chief Accounting Officer & Sr. VP
  • Byron Purcell
    VP of Investor Relations & Treasurer
  • Mr. Thomas J. Sabatino Jr. (Age 64)
    Exec. VP & Chief Legal Officer
  • Joy Errico Seusing
    Sr. VP & Chief Communications Officer
  • Ms. Jeanniey Walden
    Sr. VP & CMO
  • Ms. Jessica Kazmaier (Age 49)
    Exec. VP & Chief HR Officer
  • Ms. Karen Lesley Staniforth (Age 62)
    Sr. VP of Clinical Pharmacy Services & Chief Pharmacy Officer
  • Ms. Angele Robinson-Gaylord
    Sr. VP of Store Devel.

RAD Stock Analysis - Frequently Asked Questions

What is Rite Aid's stock price target for 2024?

0 brokerages have issued 1-year price targets for Rite Aid's stock. Their RAD share price targets range from $1.00 to $1.00. On average, they anticipate the company's stock price to reach $1.00 in the next year.
View analysts price targets for RAD
or view top-rated stocks among Wall Street analysts.

How were Rite Aid's earnings last quarter?

Rite Aid Co. (NYSE:RAD) issued its earnings results on Thursday, April, 20th. The company reported ($1.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.77) by $0.47. The business had revenue of $6.09 billion for the quarter, compared to analyst estimates of $5.70 billion. The business's revenue for the quarter was up .5% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($1.63) EPS.

When did Rite Aid's stock split?

Shares of Rite Aid reverse split before market open on Monday, April 22nd 2019. The 1-20 reverse split was announced on Wednesday, April 10th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 19th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What is Heyward Donigan's approval rating as Rite Aid's CEO?

169 employees have rated Rite Aid Chief Executive Officer Heyward Donigan on Glassdoor.com. Heyward Donigan has an approval rating of 58% among the company's employees. This puts Heyward Donigan in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Rite Aid own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rite Aid investors own include Century Aluminum (CENX), Bank of America (BAC), Akorn (AKRX), Advanced Micro Devices (AMD), Cleveland-Cliffs (CLF), Mr. Cooper Group (COOP), General Electric (GE), Micron Technology (MU) and CVS Health (CVS).

Who are Rite Aid's major shareholders?

Rite Aid's stock is owned by many different institutional and retail investors. Top institutional shareholders include Barclays PLC (0.00%), FNY Investment Advisers LLC (0.00%), Murchinson Ltd. (0.00%), Parallax Volatility Advisers L.P. (0.00%), Citadel Advisors LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Heyward R Donigan and Jocelyn Z Konrad.
View institutional ownership trends
.

Does Rite Aid have any subsidiaries?
The following companies are subsidiares of Rite Aid: 1515 West State Street Boise Idaho  LLC, 1740 Associates  LLC, 4042 Warrensville Center Road—Warrensville Ohio  Inc., 5277 Associates  Inc., 5600 Superior Properties  Inc., Advance Benefits  LLC, Apex Drug Stores  Inc., Ascend Health Technology  LLC, Bartell Drugs, Broadview and Wallings—Broadview Heights Ohio  Inc., Design Rx Holdings  LLC, Design Rx  LLC, Design Rxclusives  LLC, Drug Palace Inc., EDC Drug Stores  Inc., Eckerd Corporation, Edgehill Drugs, Elixir Holdings LLC, Elixir Insurance Company, Elixir Pharmacy LLC, Elixir Puerto Rico  Inc., Elixir Rx Options  LLC, Elixir Rx Solutions LLC, Elixir Rx Solutions of Nevada  LLC, Elixir Rx Solutions  LLC, Elixir Savings  LLC, Envision Pharmaceutical, First Florida Insurers of Tampa  LLC, GDF  Inc., Genovese Drug Stores  Inc., Gettysburg and Hoover-Dayton Ohio LLC, Grand River & Fenkell LLC, Harco, Harco  Inc., Health Dialog, Health Dialog Services Corporation, Hunter Lane  LLC, ILG – 90 B Avenue Lake Oswego LLC, JCG Holdings USA  Inc., JCG PJC USA  LLC, K&B Alabama Corporation, K&B Incorporated, K&B Industries, K&B Louisiana Corporation, K&B Mississippi Corporation, K&B Services Incorporated, K&B Tennessee Corporation, K&B Texas Corporation, LMW – 90B Avenue Lake Oswego Inc., Lakehurst and Broadway Corporation, Laker Software  LLC, Maxi Drug North  Inc., Maxi Drug South  L.P., Maxi Drug  Inc., Maxi Green  Inc., Munson & Andrews  LLC, Name Rite  LLC, P.J.C. Distribution  Inc., P.J.C. Realty Co.  Inc., PCS Health Systems, PDS-1 Michigan  Inc., PJC Lease Holdings  Inc., PJC Manchester Realty LLC, PJC Peterborough Realty LLC, PJC Realty MA  Inc., PJC Revere Realty LLC, PJC Special Realty Holdings  Inc., PJC of Massachusetts  Inc., PJC of Rhode Island  Inc., PJC of Vermont  Inc., Perry Distributors  Inc., Perry Drug Stores Inc., RCMH  LLC, RDS Detroit  Inc., READ’s Inc., RediClinic, RediClinic Associates  Inc., RediClinic US LLC, RediClinic of DC LLC, RediClinic of DE LLC, RediClinic of Dallas Forth-Worth LLC, RediClinic of MD LLC, RediClinic of PA  LLC, RediClinic of VA LLC, RediClinic LLC, Richfield Road – Flint Michigan LLC, Rite Aid Drug Palace  Inc., Rite Aid Hdqtrs. Corp., Rite Aid Hdqtrs. Funding  Inc., Rite Aid Lease Management Company, Rite Aid Online Store Inc., Rite Aid Payroll Management Inc., Rite Aid Realty Corp., Rite Aid Rome Distribution Center  Inc., Rite Aid Specialty Pharmacy LLC, Rite Aid Transport  Inc., Rite Aid of Connecticut  Inc., Rite Aid of Delaware  Inc., Rite Aid of Georgia  Inc., Rite Aid of Indiana  Inc., Rite Aid of Kentucky  Inc., Rite Aid of Maine  Inc., Rite Aid of Maryland  Inc., Rite Aid of Michigan  Inc., Rite Aid of New Hampshire  Inc., Rite Aid of New Jersey  Inc., Rite Aid of New York  Inc., Rite Aid of North Carolina  Inc., Rite Aid of Ohio  Inc., Rite Aid of Pennsylvania  LLC, Rite Aid of South Carolina  Inc., Rite Aid of Tennessee  Inc., Rite Aid of Vermont  Inc., Rite Aid of Virginia  Inc., Rite Aid of Washington D.C.  Inc., Rite Aid of West Virginia  Inc., Rite Investments Corp., Rite Investments Corp.  LLC, Rx Choice  Inc., Rx Initiatives  LLC, Rx USA Inc., The Bartell Drug Company, The Jean Coutu Group PJC USA  Inc., The Lane Drug Company, Thrift Drug Inc., Thrifty Corporation, Thrifty PayLess  Inc., and Tonic Procurement Solutions LLC.
Read More
This page (NYSE:RAD) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners